The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global β-Glucuronidase Enzymes Market Research Report 2024
Synopsis
β-Glucuronidase (GUSB) is an important lysosomal enzyme involved in the degradation of glucuronate-containing glycosaminoglycan. The deficiency of GUSB causes mucopolysaccharidosis type VII (MPSVII), leading to lysosomal storage in the brain.
The global β-Glucuronidase Enzymes market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
In terms of regions, North America is expected to remain the largest market during the forecast period.
This report aims to provide a comprehensive presentation of the global market for β-Glucuronidase Enzymes, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding β-Glucuronidase Enzymes.
Report Scope
The β-Glucuronidase Enzymes market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global β-Glucuronidase Enzymes market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the β-Glucuronidase Enzymes companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Thermo Fisher Scientific
Bio-Rad
R&D Systems
Novus Biologicals
Lifespan Biosciences
Abcam
Boster Bio
Santa Cruz Biotechnology
RayBiotech
Abbexa Ltd
Proteintech
Genetex
Biobyt
Aviva Systems Biology
Segment by Type
Above 90%
Above 95%
Above 99%
Others
Segment by Application
Biopharmaceutical Companies
Hospitals
Bioscience Research Institutions
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of β-Glucuronidase Enzymes companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
β-Glucuronidase (GUSB) is an important lysosomal enzyme involved in the degradation of glucuronate-containing glycosaminoglycan. The deficiency of GUSB causes mucopolysaccharidosis type VII (MPSVII), leading to lysosomal storage in the brain.
The global β-Glucuronidase Enzymes market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
In terms of regions, North America is expected to remain the largest market during the forecast period.
This report aims to provide a comprehensive presentation of the global market for β-Glucuronidase Enzymes, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding β-Glucuronidase Enzymes.
Report Scope
The β-Glucuronidase Enzymes market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global β-Glucuronidase Enzymes market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the β-Glucuronidase Enzymes companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Thermo Fisher Scientific
Bio-Rad
R&D Systems
Novus Biologicals
Lifespan Biosciences
Abcam
Boster Bio
Santa Cruz Biotechnology
RayBiotech
Abbexa Ltd
Proteintech
Genetex
Biobyt
Aviva Systems Biology
Segment by Type
Above 90%
Above 95%
Above 99%
Others
Segment by Application
Biopharmaceutical Companies
Hospitals
Bioscience Research Institutions
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of β-Glucuronidase Enzymes companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global β-Glucuronidase Enzymes Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Above 90%
1.2.3 Above 95%
1.2.4 Above 99%
1.2.5 Others
1.3 Market by Application
1.3.1 Global β-Glucuronidase Enzymes Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Biopharmaceutical Companies
1.3.3 Hospitals
1.3.4 Bioscience Research Institutions
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global β-Glucuronidase Enzymes Market Perspective (2019-2030)
2.2 β-Glucuronidase Enzymes Growth Trends by Region
2.2.1 Global β-Glucuronidase Enzymes Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 β-Glucuronidase Enzymes Historic Market Size by Region (2019-2024)
2.2.3 β-Glucuronidase Enzymes Forecasted Market Size by Region (2025-2030)
2.3 β-Glucuronidase Enzymes Market Dynamics
2.3.1 β-Glucuronidase Enzymes Industry Trends
2.3.2 β-Glucuronidase Enzymes Market Drivers
2.3.3 β-Glucuronidase Enzymes Market Challenges
2.3.4 β-Glucuronidase Enzymes Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top β-Glucuronidase Enzymes Players by Revenue
3.1.1 Global Top β-Glucuronidase Enzymes Players by Revenue (2019-2024)
3.1.2 Global β-Glucuronidase Enzymes Revenue Market Share by Players (2019-2024)
3.2 Global β-Glucuronidase Enzymes Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by β-Glucuronidase Enzymes Revenue
3.4 Global β-Glucuronidase Enzymes Market Concentration Ratio
3.4.1 Global β-Glucuronidase Enzymes Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by β-Glucuronidase Enzymes Revenue in 2023
3.5 β-Glucuronidase Enzymes Key Players Head office and Area Served
3.6 Key Players β-Glucuronidase Enzymes Product Solution and Service
3.7 Date of Enter into β-Glucuronidase Enzymes Market
3.8 Mergers & Acquisitions, Expansion Plans
4 β-Glucuronidase Enzymes Breakdown Data by Type
4.1 Global β-Glucuronidase Enzymes Historic Market Size by Type (2019-2024)
4.2 Global β-Glucuronidase Enzymes Forecasted Market Size by Type (2025-2030)
5 β-Glucuronidase Enzymes Breakdown Data by Application
5.1 Global β-Glucuronidase Enzymes Historic Market Size by Application (2019-2024)
5.2 Global β-Glucuronidase Enzymes Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America β-Glucuronidase Enzymes Market Size (2019-2030)
6.2 North America β-Glucuronidase Enzymes Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America β-Glucuronidase Enzymes Market Size by Country (2019-2024)
6.4 North America β-Glucuronidase Enzymes Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe β-Glucuronidase Enzymes Market Size (2019-2030)
7.2 Europe β-Glucuronidase Enzymes Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe β-Glucuronidase Enzymes Market Size by Country (2019-2024)
7.4 Europe β-Glucuronidase Enzymes Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific β-Glucuronidase Enzymes Market Size (2019-2030)
8.2 Asia-Pacific β-Glucuronidase Enzymes Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific β-Glucuronidase Enzymes Market Size by Region (2019-2024)
8.4 Asia-Pacific β-Glucuronidase Enzymes Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America β-Glucuronidase Enzymes Market Size (2019-2030)
9.2 Latin America β-Glucuronidase Enzymes Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America β-Glucuronidase Enzymes Market Size by Country (2019-2024)
9.4 Latin America β-Glucuronidase Enzymes Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa β-Glucuronidase Enzymes Market Size (2019-2030)
10.2 Middle East & Africa β-Glucuronidase Enzymes Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa β-Glucuronidase Enzymes Market Size by Country (2019-2024)
10.4 Middle East & Africa β-Glucuronidase Enzymes Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Thermo Fisher Scientific
11.1.1 Thermo Fisher Scientific Company Detail
11.1.2 Thermo Fisher Scientific Business Overview
11.1.3 Thermo Fisher Scientific β-Glucuronidase Enzymes Introduction
11.1.4 Thermo Fisher Scientific Revenue in β-Glucuronidase Enzymes Business (2019-2024)
11.1.5 Thermo Fisher Scientific Recent Development
11.2 Bio-Rad
11.2.1 Bio-Rad Company Detail
11.2.2 Bio-Rad Business Overview
11.2.3 Bio-Rad β-Glucuronidase Enzymes Introduction
11.2.4 Bio-Rad Revenue in β-Glucuronidase Enzymes Business (2019-2024)
11.2.5 Bio-Rad Recent Development
11.3 R&D Systems
11.3.1 R&D Systems Company Detail
11.3.2 R&D Systems Business Overview
11.3.3 R&D Systems β-Glucuronidase Enzymes Introduction
11.3.4 R&D Systems Revenue in β-Glucuronidase Enzymes Business (2019-2024)
11.3.5 R&D Systems Recent Development
11.4 Novus Biologicals
11.4.1 Novus Biologicals Company Detail
11.4.2 Novus Biologicals Business Overview
11.4.3 Novus Biologicals β-Glucuronidase Enzymes Introduction
11.4.4 Novus Biologicals Revenue in β-Glucuronidase Enzymes Business (2019-2024)
11.4.5 Novus Biologicals Recent Development
11.5 Lifespan Biosciences
11.5.1 Lifespan Biosciences Company Detail
11.5.2 Lifespan Biosciences Business Overview
11.5.3 Lifespan Biosciences β-Glucuronidase Enzymes Introduction
11.5.4 Lifespan Biosciences Revenue in β-Glucuronidase Enzymes Business (2019-2024)
11.5.5 Lifespan Biosciences Recent Development
11.6 Abcam
11.6.1 Abcam Company Detail
11.6.2 Abcam Business Overview
11.6.3 Abcam β-Glucuronidase Enzymes Introduction
11.6.4 Abcam Revenue in β-Glucuronidase Enzymes Business (2019-2024)
11.6.5 Abcam Recent Development
11.7 Boster Bio
11.7.1 Boster Bio Company Detail
11.7.2 Boster Bio Business Overview
11.7.3 Boster Bio β-Glucuronidase Enzymes Introduction
11.7.4 Boster Bio Revenue in β-Glucuronidase Enzymes Business (2019-2024)
11.7.5 Boster Bio Recent Development
11.8 Santa Cruz Biotechnology
11.8.1 Santa Cruz Biotechnology Company Detail
11.8.2 Santa Cruz Biotechnology Business Overview
11.8.3 Santa Cruz Biotechnology β-Glucuronidase Enzymes Introduction
11.8.4 Santa Cruz Biotechnology Revenue in β-Glucuronidase Enzymes Business (2019-2024)
11.8.5 Santa Cruz Biotechnology Recent Development
11.9 RayBiotech
11.9.1 RayBiotech Company Detail
11.9.2 RayBiotech Business Overview
11.9.3 RayBiotech β-Glucuronidase Enzymes Introduction
11.9.4 RayBiotech Revenue in β-Glucuronidase Enzymes Business (2019-2024)
11.9.5 RayBiotech Recent Development
11.10 Abbexa Ltd
11.10.1 Abbexa Ltd Company Detail
11.10.2 Abbexa Ltd Business Overview
11.10.3 Abbexa Ltd β-Glucuronidase Enzymes Introduction
11.10.4 Abbexa Ltd Revenue in β-Glucuronidase Enzymes Business (2019-2024)
11.10.5 Abbexa Ltd Recent Development
11.11 Proteintech
11.11.1 Proteintech Company Detail
11.11.2 Proteintech Business Overview
11.11.3 Proteintech β-Glucuronidase Enzymes Introduction
11.11.4 Proteintech Revenue in β-Glucuronidase Enzymes Business (2019-2024)
11.11.5 Proteintech Recent Development
11.12 Genetex
11.12.1 Genetex Company Detail
11.12.2 Genetex Business Overview
11.12.3 Genetex β-Glucuronidase Enzymes Introduction
11.12.4 Genetex Revenue in β-Glucuronidase Enzymes Business (2019-2024)
11.12.5 Genetex Recent Development
11.13 Biobyt
11.13.1 Biobyt Company Detail
11.13.2 Biobyt Business Overview
11.13.3 Biobyt β-Glucuronidase Enzymes Introduction
11.13.4 Biobyt Revenue in β-Glucuronidase Enzymes Business (2019-2024)
11.13.5 Biobyt Recent Development
11.14 Aviva Systems Biology
11.14.1 Aviva Systems Biology Company Detail
11.14.2 Aviva Systems Biology Business Overview
11.14.3 Aviva Systems Biology β-Glucuronidase Enzymes Introduction
11.14.4 Aviva Systems Biology Revenue in β-Glucuronidase Enzymes Business (2019-2024)
11.14.5 Aviva Systems Biology Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
